
Opinion|Videos|May 26, 2025
Long-Term Success: Educating and Supporting Patients on ALK Inhibitors
Panelists discuss how proactive patient education, lipid-lowering interventions, and monitoring tools can help patients stay on ALK inhibitor therapy to realize long-term benefits.
Advertisement
Episodes in this series

ALK Inhibitor Therapy Management
Main Discussion Topics
- Patient education strategies for lorlatinib therapy adherence
- Lipid-lowering interventions to support long-term lorlatinib treatment
- Monitoring tools for patients on ALK inhibitors
- Patient education methodologies specific to ALK inhibitor therapy
Discussion Questions Posed
- Grizzard inquired about proactive patient education and lipid-lowering interventions to help patients maintain lorlatinib therapy for long-term benefits
Castronovo asked about potentially useful tools for educating and monitoring patients on ALK inhibitors
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO
2
Semaglutide More Than Doubled Likelihood of MASH Resolution
3
Once-Daily Pill Zasocitinib Clears Psoriasis at Toughest Sites
4
Delgocitinib Cream Projected to Save US Health Plans Millions for Chronic Hand Eczema
5





